DERMATOLOGY SYSTEMS INC
3, 1999-10-07
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: DERMATOLOGY SYSTEMS INC, 10SB12G/A, 1999-10-07
Next: DERMATOLOGY SYSTEMS INC, 3, 1999-10-07



                                     FORM 3
OMB Approval
OMB Number 3235-0104
Expires: February 1, 1994

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

            INITIAL  STATEMENT  OF  BENEFICIAL  OWNERSHIP  OF  SECURITIES  Filed
pursuant to Section 16(a) of the securities  Exchange Act of 1934, Section 17(a)
of the  Public  Utility  Holding  Company  Act of 1935 or  Section  30(f) of the
Investment Company Act of 1940

___ Check if no longer subject to Section 16, Form 4 or Form 5,
       Obligation may continue.  See Instructions
_X_ Form 3 Holdings Reported
___ Form 4 Transaction

<TABLE>
<S>                                                    <C>

1. Name and Address of Reporting Person:               Haouzi, Dr.  Pierre
                                                       222 Lakeview Ave., Suite 113
                                                       West Palm Beach, FL   33401
2. Date of Event Requiring Statement:                  08/31/99
3. IRS or SSN of Reporting Person (Voluntary):
4. Issuer Name and Tickler or Trading Symbol:          Dermatology Systems, Inc.
5. Relation of Reporting Person to Issuer              X Director
                                                       X 10% owner
                                                       X Officer (Title): President, CEO
                                                       _ Other (Specify)
6. If Amendment, Date of Original:
7.      X Filed  by One  Reporting  Person.
        _ Filed by more than One Reporting Person.
</TABLE>

TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
1. Title of Security:                   Common Stock
2. Amount of Securities
Beneficially Owned:                     850,000
3. Ownership Form;
Direct (D) or Indirect (I):             D
4. Nature of Indirect Beneficial
Ownership:                              N/A
*If the form is filed by more than one Reporting Person, see instruction 5(b)(v)
Reminder:  Report on a separate Line for each class of  securities  beneficially
owned directly or indirectly.




<PAGE>




TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED
1.  Title of Derivative Security:                           N/A
2. Date Exercisable and Expiration Date:
3. Title and Amount of Underlying Securities:
4. Conversion or Exercise Price of Derivative
   Securities:
5. Ownership of Derivative Securities;   Direct (D) or Indirect (I):
6. Nature of Indirect Benefical Ownership:
EXPLANATION OF RESPONSES:




/s/ Dr.  Pierre Haouzi                                       Date: 10/02/99
- ------------------------------------------------

**   Signature of Reporting Person
**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See Sections 18 U.S.C. 1001, 15 U.S.C. 78ff(a).






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission